Terms: = Sarcomas AND FGFR3, CD333, 2261, ENSG00000068078, P22607, JTK4, ACH, HSFGFR3EX, CEK2 AND Prognosis
6 results:
1. Epithelioid sarcoma: A single-institutional retrospective cohort study of 36 cases.
Zhang S; Jing C; Liu H; Zhao Z; Zhang X; Liu T; Xu S; Xu L; Yu S
J Orthop Surg (Hong Kong); 2021; 29(3):23094990211029349. PubMed ID: 34405755
[TBL] [Abstract] [Full Text] [Related]
2. Comprehensive characterization of circular RNAs in osteosarcoma cell lines.
Xiong W; Zhang Y; Yu H
Cell Signal; 2020 Jul; 71():109603. PubMed ID: 32199934
[TBL] [Abstract] [Full Text] [Related]
3. Oncogene mutation profiling reveals poor prognosis associated with FGFR1/3 mutation in liposarcoma.
Li C; Shen Y; Ren Y; Liu W; Li M; Liang W; Liu C; Li F
Hum Pathol; 2016 Sep; 55():143-50. PubMed ID: 27237367
[TBL] [Abstract] [Full Text] [Related]
4. Apurinic/apyrimidinic endonuclease 1 induced upregulation of fibroblast growth factor 2 and its receptor 3 induces angiogenesis in human osteosarcoma cells.
Ren T; Qing Y; Dai N; Li M; Qian C; Yang Y; Cheng Y; Li Z; Zhang S; Zhong Z; Wang D
Cancer Sci; 2014 Feb; 105(2):186-94. PubMed ID: 24329908
[TBL] [Abstract] [Full Text] [Related]
5. Expression of fgfr3 and FGFR4 and clinical risk factors associated with progression-free survival in synovial sarcoma.
Charbonneau B; Vogel RI; Manivel JC; Rizzardi A; Schmechel SC; Ognjanovic S; Subramanian S; Largaespada D; Weigel B
Hum Pathol; 2013 Sep; 44(9):1918-26. PubMed ID: 23664540
[TBL] [Abstract] [Full Text] [Related]
6. Screening for potential targets for therapy in mesenchymal, clear cell, and dedifferentiated chondrosarcoma reveals Bcl-2 family members and TGFβ as potential targets.
van Oosterwijk JG; Meijer D; van Ruler MA; van den Akker BE; Oosting J; Krenács T; Picci P; Flanagan AM; Liegl-Atzwanger B; Leithner A; Athanasou N; Daugaard S; Hogendoorn PC; Bovée JV
Am J Pathol; 2013 Apr; 182(4):1347-56. PubMed ID: 23415961
[TBL] [Abstract] [Full Text] [Related]
